EUVIMEDEUVIMED entdecken
Crossref

Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?

João Sérgio Neves, Faiez Zannad, Javed Butler, Milton Packer, João Pedro Ferreira

Journal of the American College of Cardiology · 2024

DOI: 10.1016/j.jacc.2024.06.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von João Sérgio Neves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Departmen…. Hauptthemen laut MEDLINE: Heart Failure, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureGlucagon-Like Peptide-1 Receptor AgonistsHumansStroke VolumeClinical Trials as Topic

Stichwörter der Autor:innen

event riskheart failuresemaglutide

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Department of Endocrinology, Diabetes and Metabolism, Faculty of Medicine of th…
  • Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique, and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
  • Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Baylor University Medical Center, Dallas, Texas, USA; Imperial College, London, United Kingdom.
  • Cardiovascular R&D Centre-UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal; Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématiq…

Zitieren

APA

Neves, J. S., Zannad, F., Butler, J., Packer, M., & Ferreira, J. P. (2024). Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.06.026

Vancouver

Neves JS, Zannad F, Butler J, Packer M, Ferreira JP. Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.06.026

BibTeX
@article{Neves2024,
  author = {Neves, João Sérgio and Zannad, Faiez and Butler, Javed and Packer, Milton and Ferreira, João Pedro},
  title = {Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  doi = {10.1016/j.jacc.2024.06.026}
}
Kostenlos starten →